NDAINJECTIONINJECTABLE
Approved
Dec 1988
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
2/8 — Basic
OPTIRAY 300 (ioversol) by Guerbet is x-ray contrast activity [moa]. First approved in 1988.
Drug data last refreshed 18h ago · AI intelligence enriched 1w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
OPTIRAY 300 (ioversol) is an injectable radiographic contrast agent used to enhance X-ray imaging during diagnostic procedures. It works through X-ray contrast activity to improve visualization of internal structures. The drug belongs to the radiographic contrast agent class and is administered via injection.
LOE Approaching
With LOE approaching and moderate competitive pressure (30), teams supporting this product face transition planning and potential downsizing opportunities for those seeking growth-stage roles.
Mechanism of Action
X-Ray Contrast Activity
Pharmacologic Class:
Radiographic Contrast Agent
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on OPTIRAY 300 offers limited growth opportunity due to LOE-approaching status and zero linked job openings, making it a role suited for experienced professionals managing mature product transitions rather than those seeking career advancement. This position is better for specialists in generic transition, healthcare economics, or regional market management.
Brand Manager
Worked on OPTIRAY 300 at Guerbet? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.